Under-representation of key demographic groups in opioid use disorder trials

BACKGROUND: The extent to which clinical trials of medications for opioid use disorder (MOUD) are representative or not is unknown. Some patient characteristics modify MOUD effectiveness; if these same characteristics differ in distribution between the trial population and usual-care population, thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudolph, Kara E., Russell, Matthew, Luo, Sean X., Rotrosen, John, Nunes, Edward V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524855/
https://www.ncbi.nlm.nih.gov/pubmed/36187300
http://dx.doi.org/10.1016/j.dadr.2022.100084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524855/
https://www.ncbi.nlm.nih.gov/pubmed/36187300
http://dx.doi.org/10.1016/j.dadr.2022.100084

Ejemplares similares